The Federal Government’s Coronavirus Cabinet discussed the supply of medical personal protection equipment (PPE), test kits, and active ingredients today. The discussions focused on how to foster and expand the production of PPE in Germany and Europe. and Federal Minister of Health Jens Spahn gave a joint press statement on the subject.
The following key points on how to foster and boost the production of PPE, test kits, and active ingredients have been agreed:
Public health must be the number-one priority. PPE plays a key role in protecting public health. Having a sufficient supply with PPE is a priority for the Federal Government. Demand for PPE is currently high and can expected to remain at a high level in the short and medium term.
This is why, on 30 March 2020, the Federal Government established a Procurement Task Force in the Federal Ministry of Health, which has been and will continue to coordinate and organise the procurement of PPE.
In addition to this, the Federal Ministry for Economic Affairs and Energy is now introducing a new Task Force for Production Capacity and Production Processes, which will be tasked with building up national and European value chains for PPE, test kits, and active ingredients and Germany and in the European Union in the short term, thereby making an essential contribution to the supply for the medium term.
The Task Force will focus on enabling and fostering private-sector investment in production capacity. The Federal Government will support companies with funding and provide scope for investors to plan for the long term.
The Task Force will be led by the Federal Ministry for Economic Affairs and Energy and also include representatives from the Federal Ministry of Health, the Federal Ministry of Finance, the Federal Ministry of Labour and Social Affairs, the Federal Ministry of Transport and Digital Infrastructure, and the Federal Chancellery.